product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
IKKβ Antibody
catalog :
2684P
quantity :
40 ul
price :
123 USD
clonality :
polyclonal
host :
rabbit
reactivity :
human, mouse
application :
western blot
citations: 5
Published Application/Species/DilutionReference
  • western blot; mouse; fig s2
Takahashi N, Vereecke L, Bertrand M, Duprez L, Berger S, Divert T, et al. RIPK1 ensures intestinal homeostasis by protecting the epithelium against apoptosis. Nature. 2014;513:95-9 pubmed publisher
Dong T, Li C, Wang X, Dian L, Zhang X, Li L, et al. Ainsliadimer A selectively inhibits IKKα/β by covalently binding a conserved cysteine. Nat Commun. 2015;6:6522 pubmed publisher
Tagoug I, Sauty De Chalon A, Dumontet C. Inhibition of IGF-1 signalling enhances the apoptotic effect of AS602868, an IKK2 inhibitor, in multiple myeloma cell lines. PLoS ONE. 2011;6:e22641 pubmed publisher
Shibata Y, Oyama M, Kozuka-Hata H, Han X, Tanaka Y, Gohda J, et al. p47 negatively regulates IKK activation by inducing the lysosomal degradation of polyubiquitinated NEMO. Nat Commun. 2012;3:1061 pubmed publisher
Pallotta M, Orabona C, Volpi C, Vacca C, Belladonna M, Bianchi R, et al. Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells. Nat Immunol. 2011;12:870-8 pubmed publisher
product information
SKU :
2684P
Product-Name :
IKKβ Antibody
Size :
40 ul
Price-(USD) :
123 USD
Species-x-Reactivity :
H, Mk
Applications :
Western blot
Product-Category :
Immunology and Inflammation
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
87
Host :
Rabbit
Target :
IKK-beta
Primary-Protein :
IKK-beta
Alt-Names :
FLJ40509,I-kappa-B kinase 2,I-kappa-B-kinase beta,IKBKB,IKK-B,IKK-beta,IKK2,IKKB,Inhibitor of nuclear factor kappa-B kinase subunit beta,MGC131801,NFKBIKB,Nuclear factor NF-kappa-B inhibitor kinase beta,inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.